Abstract:Background: SUMOylation, as part of the epigenetic regulation of transcription, has been intensively studied in lower eukaryotes that contain only a single SUMO protein; however, the functions of SUMOylation during mammalian epigenetic transcriptional regulation are largely uncharacterized. Mammals express three major SUMO paralogues: SUMO-1, SUMO-2, and SUMO-3 (normally referred to as SUMO-1 and SUMO-2/3). Herpesviruses, including Kaposi's sarcoma associated herpesvirus (KSHV), seem to have evolved mechanisms that directly or indirectly modulate the SUMO machinery in order to evade host immune surveillance, thus advancing their survival. Interestingly, KSHV encodes a SUMO E3 ligase, K-bZIP, with specificity toward SUMO-2/3 and is an excellent model for investigating the global functional differences between SUMO paralogues.Results: We investigated the effect of experimental herpesvirus reactivation in a KSHV infected B lymphoma cell line on genomic SUMO-1 and SUMO-2/3 binding profiles together with the potential role of chromatin SUMOylation in transcription regulation. This was carried out via high-throughput sequencing analysis. Interestingly, chromatin immunoprecipitation sequencing (ChIP-seq) experiments showed that KSHV reactivation is accompanied by a significant increase in SUMO-2/3 modification around promoter regions, but SUMO-1 enrichment was absent. Expression profiling revealed that the SUMO-2/3 targeted genes are primarily highly transcribed genes that show no expression changes during viral reactivation. Gene ontology analysis further showed that these genes are involved in cellular immune responses and cytokine signaling. High- throughput annotation of SUMO occupancy of transcription factor binding sites (TFBS) pinpointed the presence of three master regulators of immune responses, IRF-1, IRF-2, and IRF-7, as potential SUMO-2/3 targeted transcriptional factors after KSHV reactivation.Conclusion: Our study is the first to identify differential genome-wide SUMO modifications between SUMO paralogues during herpesvirus reactivation. Our findings indicate that SUMO-2/3 modification near protein-coding gene promoters occurs in order to maintain host immune-related gene unaltered during viral reactivation.

Modulation of Global SUMOylation by Kaposi's Sarcoma-Associated Herpesvirus and Its Effects on Viral Gene Expression.

The Chromatin Modification by Sumo-2/3 but Not Sumo-1 Prevents the Epigenetic Activation of Key Immune-Related Genes During Kaposi'S Sarcoma Associated Herpesvirus Reactivation

Role of SUMOylation in Human Oncogenic Herpesvirus Infection

Linear Ubiquitination Regulates the KSHV Replication and Transcription Activator Protein to Control Infection

Analysis of the ubiquitin-modified proteome identifies novel host factors in Kaposi’s sarcoma herpesvirus lytic reactivation

SUMO modification of a heterochromatin histone demethylase JMJD2A enables viral gene transactivation and viral replication

Kaposi's Sarcoma-Associated Herpesvirus RTA Activates the Processivity Factor ORF59 Through Interaction with RBP-Jkappa and a Cis-Acting RTA Responsive Element.

The SUMO E3 ligase activity of ORF45 determines KSHV lytic replication.

Cellular MicroRNAs 498 and 320d Regulate Herpes Simplex Virus 1 Induction of Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication by Targeting RTA

Regulation of viral and cellular gene expression by Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA

KSHV RTA Antagonizes SMC5/6 Complex-Induced Viral Chromatin Compaction by Hijacking the Ubiquitin-Proteasome System

RSK1 SUMOylation is Required for KSHV Lytic Replication

Viral activation of MK2-hsp27-p115RhoGEF-RhoA signaling axis causes cytoskeletal rearrangements, p-body disruption and ARE-mRNA stabilization

MicroRNAs Encoded by Kaposi's Sarcoma‐associated Herpesvirus Regulate Viral Life Cycle

Upregulation Of Cellular Bcl-2 By The Kshv Encoded Rta Promotes Virion Production

The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 to Facilitate Establishment of Latency.

KSHV Manipulation of Antigen Presentation via the Ubiquitin Proteasome System

Mir-K12-7-5p Encoded by Kaposi's Sarcoma-Associated Herpesvirus Stabilizes the Latent State by Targeting Viral ORF50/RTA.

Nuclear Localization and Cleavage of STAT6 is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.

Nuclear body reorganization by the viral RNA kaposin promotes Kaposi's sarcoma-associated herpesvirus gene expression

The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.